SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor is trending as the community discusses the appointment of Kaz Nejatian, former COO of Shopify, as the new CEO, and the return of co-founders Keith Rabois and Eric Wu to the Board.  The news is sparking excitement and speculation about the company's future direction, with many anticipating a potential short squeeze and a shift towards an AI-first real estate platform.  Overall, the leadership changes are seen as a positive catalyst, injecting fresh energy and expertise into the company.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media is trending amid heated online discussions, with community members expressing strong opinions and political views. The catalyst appears to be an incident involving political violence, sparking debates about freedom of speech, gun control, and the current political climate. The conversation also touches on broader themes, including social division, extremist ideologies, and the role of political leaders in shaping public discourse.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is trending amid reports of a shooting involving conservative figure Charlie Kirk, sparking heated debate and political commentary within the community. Discussions range from the implications of political violence to gun control and broader societal divisions. The incident occurs ahead of CPI data, adding another layer of uncertainty to the market's direction.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending due to a recently filed $300M mixed securities shelf, leading to community debate about potential dilution and the company's financial strategy. Some investors express concern over increasing expenses and the need for funding, while others believe the shelf registration is a strategic move to capitalize on market movements. Amidst the uncertainty, there's discussion around upcoming FDA meeting minutes and their potential impact on the company's regulatory path for its lead drug candidate.

Armada Acquisition Corp. I operates as a blank check company. It was formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. The company was founded on November 5, 2020 and is headquartered in Philadelphia, PA.

Rezolve AI PLC .

Rezolve AI Limited

Rezolve AI (RZLV) is trending due to increased investor attention and a recent company presentation, with the community highlighting its potential for growth within the AI-driven e-commerce sector. Discussions revolve around the company's strong fundamentals, potential for a valuation re-rate, and comparisons to other AI stocks like PLTR. Some traders are also pointing to potentially significant gains pending the upcoming earnings release.

Wearable Devices Ltd. engages in the development of a non-invasive neural input technology that allows operation and control of digital devices using subtle finger movements and fingertip pressure. It offers Mudra band, a neutral input wristband. The company was founded by Asher Dahan, Guy Wagner, and Leeor Langer in March 2014 and is headquartered in Yokne'am Illit, Israel.

Wearable Devices Ltd

WLDS is trending due to a recently granted patent for voice and gesture control technology, sparking discussions about potential acquisitions from major tech players like Apple and Meta. Community members are actively debating the stock's valuation, potential buyout prices, and likelihood of a short squeeze, while also weighing the risks of dilution and historical stock behavior. The stock's low float and high volatility are contributing to the intense interest and trading activity.

Enovix Corp. engages in the design and development of silicon-anode lithium-ion batteries. The firm's proprietary 3D cell architecture increases energy density and maintains a high cycle life. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable utilization of renewable energy. The company was founded by Mr. Harrold Jones Rust, III, Ashok Lahiri, and Murali Ramasubramanian in November 2006 and is headquartered in Fremont, CA.

Enovix Corporation

Enovix Corp

Enovix is trending amid discussions about a recent offering and its potential impact on investors, with some fearing dilution while others speculate about acquisitions. Community members are debating the company's cash position and the implications for future growth, including possible deals or expansion into new markets. Some are also following developments of the Solana meme coin $KIRK.X

"Shina Inu is a decentralized meme token on the Ethereum blockchain. Its mission is to give back to the crypto community, give to charity, and win the heart of the greatest token of all time, Shiba Inu!   Shina Token is a very fun meme token project that has sold many rare and beautiful NFTs. NFT sales are used to support the team and provide upcoming features such as exclusive access to events and rewards that will soon be announced."

Shina Inu

Shina Inu is trending as community members highlight bullish chart patterns and strong accumulation, anticipating a potential breakout soon. The community emphasizes the growing strength and organic engagement around the project. Some users are drawing comparisons to Shiba Inu, noting potential connections.

Sharps Technology, Inc. is a medical device and pharmaceutical packaging company, which engages in the development and manufacturing of innovative drug delivery systems. It also focuses on low waste, and ultra-low waste syringe technologies that incorporate both passive and active safety features. The company was founded by Alan R. Blackman and Barry B. Berler on December 16, 2017 and is headquartered in Melville, NY.

Sharps Technology Inc

STSS is trending due to a recent partnership with Pudgy Penguins to expand its Solana digital asset treasury exposure, sparking community discussions around valuation and potential short squeezes. The stock's low float and high short interest are fueling speculation about significant price movement, with community members actively mapping out potential short versus long battle zones. Community members are closely watching the company's ties to Solana and speculating on future price targets.

SSgA Active Trust - SPDR Dow Jones Industrial Average ETF

The SPDR Dow Jones Industrial Average ETF ($DIA) is trending amid discussions about interest rate cuts, inflation data, and upcoming economic reports, with some analysts anticipating a potential market correction. Community members are closely watching key economic indicators this week for signals on the Federal Reserve's next moves, while also debating the impact of AI and tariff policies on the broader market and specific sectors.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of Alzamend Neuro, Inc. (ALZN) soared 82% on Thursday afternoon after the company <a target="_blank" rel="noopener noreferrer nofollow" href="https://ir.alzamend.com/news-events/press-releases/detail/93/alzamend-neuro-announces-dosing-of-first-patient-in-its">announced</a> the dosing of the first patient in its first Phase II clinical study of AL001 in healthy human subjects.AL001 is a novel lithium-delivery system that has the potential to provide the benefits of marketed lithium salts while mitigating currently experienced toxicities associated with lithium.The system is designed to favorably distribute lithium in the brain, resulting in lower exposure of other body organs and an improved safety profile compared to currently marketed lithium salts.The study in healthy human subjects is expected to help the company determine the best path forward in Alzheimer’s disease, bipolar disorder, major depressive disorder, and post-traumatic stress disorder patients by demonstrating AL001’s targeted effectiveness and reduced systemic side effects, the company said.Lithium is known for its efficacy as a first-line therapy for manic episodes and maintenance in bipolar disorder.However, current lithium salts require regular lithium therapeutic drug monitoring of plasma lithium levels and blood chemistry by a clinician to mitigate adverse events that could affect the kidneys and thyroid.Alzamend said that AL001 would potentially eliminate the need for lithium therapeutic drug monitoring. The company’s previous studies in mice have shown that AL001 ensures better brain absorption while maintaining lower levels of lithium in the blood, it addedAlzamend CEO Stephan Jackman said that the company is expected to announce data from the new study before the end of the year.“This advancement stands to potentially enhance the lives of over 43 million Americans suffering from Alzheimer’s, BD, MDD, and PTSD,” he added.On Stocktwits, retail sentiment around Alzamend jumped from ‘neutral’ to ‘extremely bullish’ over the past 24 hours while message volume soared from ‘extremely low’ to ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:630/63;" src="https://news.stocktwits-cdn.com/Screenshot_2025_05_29_at_1_18_03_PM_png_9982df14f5.webp" alt="ALZN's Sentiment Meter and Message Volume as of 1:18 p.m. ET on May 29, 2025 | Source: Stocktwits" width="630" height="63"><figcaption>ALZN's Sentiment Meter and Message Volume as of 1:18 p.m. ET on May 29, 2025 | Source: Stocktwits</figcaption></figure> <a href="https://stocktwits.com/symbol/ALZN">ALZN stock</a> is down by about 44% this year and by about 88% over the past 12 months.Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/uber-stock-falls-after-tesla-s-june-12-robotaxi-launch-report/ch0AH7SRbtU">Uber Stock Falls After Tesla’s June 12 Robotaxi Launch Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

Alzamend Neuro Stock Rockets On Dosing Of First Human Patient With Lithium-Delivery System AL001 In Phase II Study: Retail’s Thrilled

AL001 has the potential to provide the benefits of marketed lithium salts while mitigating currently experienced toxicities associated with lithium.

Equity

Alzamend Neuro Announces Completion of a Novel Head Coil by Tesla for Measuring Brain Structure Lithium Levels in Five Upcoming Phase II Clinical Trials at Massachusetts General Hospital

Alzamend Neuro, Inc. (Nasdaq: ALZN) (Alzamend), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimers disease (Alzheimers), bipolar disorder...

Alzamend Neuro to Present at the Sequire Investor Summit

Alzamend Neuro, Inc. (Nasdaq: ALZN) (Alzamend), a clinical-stage biopharmaceutical company, focused on developing novel products for the treatment of Alzheimers disease (Alzheimers), bipolar disorder...

Alzamend Neuro to Present Non-Clinical Data Update at the Society of Toxicology 2025 Annual Meeting and ToxExpo

Alzamend Neuro Reports Second Quarter 2025 Financial Results and Provides Update on Clinical Programs

Alzamend Neuro Announces Full Data Set from its Nonclinical Study: Comparing Brain and Plasma Lithium Exposures between AL001 and Lithium Carbonate in Alzheimers Transgenic Mice

EXCLUSIVE: Alzamend Neuro Reveals Full Data From Nonclinical Study Of Its Lead Alzheimer's Drug Potential

Alzamend Neuro's AL001 study highlights safety and therapeutic potential for Alzheimer's and psychiatric conditions, reducing systemic side effects.
read more...

Alzamend Neuro Announces Full Data Set from Phase IIA Multiple Ascending Dose Clinical Trial for AL001 Treatment of Dementia Related to Alzheimers

Alzamend Neuro Regains Compliance with Nasdaq Listing Standards

Alzamend Neuro CEO Stephan Jackman to Participate in the Maxim Groups Virtual Healthcare Conference

Alzamend Neuro, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001, which is in Phase II clinical trial, and delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bipolar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders, and AL002, which completed preclinical stage, and uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. The company was founded on February 26, 2016 by Milton C. Ault, III and is headquartered in Atlanta, GA.

Alzamend Neuro Inc

Buying for a long-term investment

Buying for a short-term trade

Trading around the volatility

Avoiding it

$KLAR IPO day is upon us, how are you playing it?

Stocktwits

Klarna Group plc

 IPO day is upon us, how are you playing it?

ALZN
Alzamend Neuro Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ALZN News

ALZN Alzamend Neuro Inc